Drug Pipeline

DRP-104 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
2
Top Sponsors
Active Studies by Phase
Phase 2
1
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07249372 DRP-104 in Patients With NFE2L2/KEAP1-altered Non-Small Cell Lung Cancer Non Small Cell Lung Cancer Recruiting
Phase 1/2
NCT06027086 DRP-104 (Glutamine Antagonist) in Combination With Durvalumab in Patients With Advanced… Fibrolamellar Hepatocellular Carcinoma Recruiting
Phase 1
NCT07430202 A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104… Liver Cancer (Fibrolamellar Hepatocellular Cancer (FLC)) Not Yet Recruiting
Sponsors Running DRP-104 Trials
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (2) NYU Langone Health (1)
Disease Areas
Liver Cancer (2) Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1)
Get alerts when DRP-104 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free